Lipella Pharmaceuticals Inc. (LIPO) Revenue History
Annual and quarterly revenue from 2019 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
LIPO Revenue Growth
Revenue Breakdown (FY 2022)
LIPO's revenue distribution by segment and geography for fiscal year 2022
By Product/Segment
LIPO Revenue Analysis (2019–2024)
As of May 8, 2026, Lipella Pharmaceuticals Inc. (LIPO) generated trailing twelve-month (TTM) revenue of $173,666, reflecting significant decline in growth of -100.0% year-over-year. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, LIPO's 5-year compound annual growth rate (CAGR) stands at -5.0%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $961,683 in 2020.
Revenue diversification analysis shows LIPO's business is primarily driven by Grant Revenues (100%). With over half of revenue concentrated in Grant Revenues, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including SIGA (-22.1% YoY), and INVA (+13.6% YoY), LIPO has underperformed the peer group in terms of revenue growth. Compare LIPO vs SIGA →
LIPO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| LIPOCurrent | $173,666 | -100.0% | -5.0% | -947.2% | |
 SIGA | $95M | -22.1% | -5.4% | 25.1% | |
 INVA | $425M | +13.6% | +4.8% | 38.5% |
LIPO Historical Revenue Data (2019–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $536K | +19.3% | $-3,076,830 | -573.7% | $-5,080,542 | -947.2% |
| 2023 | $450K | +144.2% | $-2,589,219 | -575.9% | $-4,745,953 | -1055.6% |
| 2022 | $184K | -29.0% | $-2,363,521 | -1283.4% | $-2,589,713 | -1406.3% |
| 2021 | $259K | -73.0% | $-1,197,444 | -461.7% | $-1,915,828 | -738.7% |
| 2020 | $962K | +38.4% | $-14,277 | -1.5% | $-56,862 | -5.9% |
| 2019 | $695K | - | $12K | 1.7% | $-53,791 | -7.7% |
See LIPO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LIPO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LIPO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLIPO — Frequently Asked Questions
Quick answers to the most common questions about buying LIPO stock.
Is LIPO's revenue growth accelerating or slowing?
LIPO revenue declined -100.0% year-over-year, contrasting with the 5-year CAGR of -5.0%. TTM revenue fell to $173666.00. This reverses the prior growth trend.
What is LIPO's long-term revenue growth rate?
Lipella Pharmaceuticals Inc.'s 5-year revenue CAGR of -5.0% reflects the variable expansion pattern. Current YoY growth of -100.0% is below this long-term average.
How is LIPO's revenue distributed by segment?
LIPO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2024 are available for download. Segment mix reveals concentration and diversification trends.